These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2066 related items for PubMed ID: 15979893

  • 1. Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
    Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P.
    Pharmacol Res; 2005 Oct; 52(4):313-20. PubMed ID: 15979893
    [Abstract] [Full Text] [Related]

  • 2. PPAR gamma agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance.
    Gaikwad AB, Viswanad B, Ramarao P.
    Pharmacol Res; 2007 May; 55(5):400-7. PubMed ID: 17369046
    [Abstract] [Full Text] [Related]

  • 3. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
    Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM.
    Metabolism; 2000 Nov; 49(11):1390-4. PubMed ID: 11092499
    [Abstract] [Full Text] [Related]

  • 4. Reversal of glucose intolerance by by pioglitazone in high fat diet-fed rats.
    Srinivasan K, Patole PS, Kaul CL, Ramarao P.
    Methods Find Exp Clin Pharmacol; 2004 Jun; 26(5):327-33. PubMed ID: 15319810
    [Abstract] [Full Text] [Related]

  • 5. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ.
    Acta Pharmacol Sin; 2005 May; 26(5):575-80. PubMed ID: 15842776
    [Abstract] [Full Text] [Related]

  • 6. [Effect of the duration of high-fat diet and the dosage of streptozotocin on establishing experimental animal model of type 2 diabetes mellitus].
    Wang B, Li Y, Liu X, Liu S, Sun C.
    Wei Sheng Yan Jiu; 2011 Jan; 40(1):99-102, 106. PubMed ID: 21434325
    [Abstract] [Full Text] [Related]

  • 7. Anti-diabetic activity of chromium picolinate and biotin in rats with type 2 diabetes induced by high-fat diet and streptozotocin.
    Sahin K, Tuzcu M, Orhan C, Sahin N, Kucuk O, Ozercan IH, Juturu V, Komorowski JR.
    Br J Nutr; 2013 Jul 28; 110(2):197-205. PubMed ID: 23211098
    [Abstract] [Full Text] [Related]

  • 8. Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.
    Wang Y, Campbell T, Perry B, Beaurepaire C, Qin L.
    Metabolism; 2011 Feb 28; 60(2):298-305. PubMed ID: 20304443
    [Abstract] [Full Text] [Related]

  • 9. Metabolic effects of various antidiabetic and hypolipidaemic agents on a high-fat diet and multiple low-dose streptozocin (MLDS) mouse model of diabetes.
    Arulmozhi DK, Kurian R, Bodhankar SL, Veeranjaneyulu A.
    J Pharm Pharmacol; 2008 Sep 28; 60(9):1167-73. PubMed ID: 18718120
    [Abstract] [Full Text] [Related]

  • 10. Establishment of a rat model of type II diabetic neuropathic pain.
    Dang JK, Wu Y, Cao H, Meng B, Huang CC, Chen G, Li J, Song XJ, Lian QQ.
    Pain Med; 2014 Apr 28; 15(4):637-46. PubMed ID: 24716590
    [Abstract] [Full Text] [Related]

  • 11. Obesity and diabetes - a possible experimental model of maturity-onset-type diabetes.
    Inoue S, Iizuka T, Murao S.
    Int J Obes; 1982 Apr 28; 6 Suppl 1():27-33. PubMed ID: 6214517
    [Abstract] [Full Text] [Related]

  • 12. Antidiabetic effects of total flavonoids from Litsea Coreana leve on fat-fed, streptozotocin-induced type 2 diabetic rats.
    Lu YX, Zhang Q, Li J, Sun YX, Wang LY, Cheng WM, Hu XY.
    Am J Chin Med; 2010 Apr 28; 38(4):713-25. PubMed ID: 20626057
    [Abstract] [Full Text] [Related]

  • 13. Antidiabetic effect of Dodonaea viscosa aerial parts in high fat diet and low dose streptozotocin-induced type 2 diabetic rats: a mechanistic approach.
    Veerapur VP, Prabhakar KR, Kandadi MR, Srinivasan KK, Unnikrishnan MK.
    Pharm Biol; 2010 Oct 28; 48(10):1137-48. PubMed ID: 20815701
    [Abstract] [Full Text] [Related]

  • 14. Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
    Chao PC, Li Y, Chang CH, Shieh JP, Cheng JT, Cheng KC.
    Biomed Pharmacother; 2018 May 28; 101():155-161. PubMed ID: 29486333
    [Abstract] [Full Text] [Related]

  • 15. Diosgenin reorganises hyperglycaemia and distorted tissue lipid profile in high-fat diet-streptozotocin-induced diabetic rats.
    Naidu PB, Ponmurugan P, Begum MS, Mohan K, Meriga B, RavindarNaik R, Saravanan G.
    J Sci Food Agric; 2015 Dec 28; 95(15):3177-82. PubMed ID: 25530163
    [Abstract] [Full Text] [Related]

  • 16. Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat.
    Sahin K, Onderci M, Tuzcu M, Ustundag B, Cikim G, Ozercan IH, Sriramoju V, Juturu V, Komorowski JR.
    Metabolism; 2007 Sep 28; 56(9):1233-40. PubMed ID: 17697867
    [Abstract] [Full Text] [Related]

  • 17. Appropriate Insulin Level in Selecting Fortified Diet-Fed, Streptozotocin-Treated Rat Model of Type 2 Diabetes for Anti-Diabetic Studies.
    Okoduwa SI, Umar IA, James DB, Inuwa HM.
    PLoS One; 2017 Sep 28; 12(1):e0170971. PubMed ID: 28129400
    [Abstract] [Full Text] [Related]

  • 18. Effect of masoprocol on carbohydrate and lipid metabolism in a rat model of Type II diabetes.
    Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Brignetti D, Luo J, Khandwala A, Reaven GM.
    Diabetologia; 1999 Jan 28; 42(1):102-6. PubMed ID: 10027587
    [Abstract] [Full Text] [Related]

  • 19. Anti-diabetic activity of the semi-purified fractions of Averrhoa bilimbi in high fat diet fed-streptozotocin-induced diabetic rats.
    Tan BK, Tan CH, Pushparaj PN.
    Life Sci; 2005 Apr 29; 76(24):2827-39. PubMed ID: 15808883
    [Abstract] [Full Text] [Related]

  • 20. Westernized-like-diet-fed rats: effect on glucose homeostasis, lipid profile, and adipocyte hormones and their modulation by rosiglitazone and glimepiride.
    Schaalan M, El-Abhar HS, Barakat M, El-Denshary ES.
    J Diabetes Complications; 2009 Apr 29; 23(3):199-208. PubMed ID: 18407527
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 104.